News archive: 2007

Tuesday, 23rd January 2007

Clinical Trials A Practical Guide to Design, Analysis & Reporting.

Clinical Trials A Practical Guide to Design, Analysis, and Reporting by Duolao Wang, (PhD) and Ameet Bakhai (MBBS, MRCP) is the result of a unique collaboration between two experts in the exciting fields of medicine & science.

Read more…

Tuesday, 15th May 2007

May Newsletter

Accreditation of Phase I units in the UK, Are you in the process of planning your outsourcing needs for the coming months?, Volunteer Recruitment, Pharma-Bio Outsourcing Conference & Exhibition and The Head of RPLs Data Management department applies the Richmond work ethic to his Marathon run!

Read more…

Thursday, 11th October 2007

2007's most comprehensive QT & Safety Pharmacology Strategy Congress takes place in just under two weeks!

The pre-conference workshop will be hosted by Richmond Pharmacology; the leading Trial Centre and ECG Core Lab for conducting QTc studies. The workshop will address 'Key Issues and Best Practice in Conducting a Definitive Thorough QTc Study'.

Read more…

Monday, 29th October 2007

Community Conscience

Richmond Pharmacology 'Get in the Pink' for Breast Cancer Awareness Month

Read more…

Tuesday, 30th October 2007

The reference book you cannot live without.

Clinical Trials - A Practical Guide to Design, Analysis, and Reporting by Duolao Wang, (PhD) and Ameet Bakhai (MBBS, MRCP) is the result of a unique collaboration between two experts in the exciting fields of medicine & science. The publication seamlessly integrates important contributions from leading clinicians in the research field, including Richmond Pharmacology's own Dr Radivoj Arezina, MD MSc, Research Director, and Dr Ulrike Lorch, MD, FRCA, MFPM, Medical Director.

Read more…

Tuesday, 20th November 2007

2nd Cardiac Safety Conference

ICH E14 QT Guidance were finalised (step 4) in May 2005. However, implementation of the new guidance (step 5) seems to have taken a different pace in different ICH regions, with US FDA leading the trend and Japan PMDA still developing their own version.

Read more…

Wednesday, 12th December 2007

October Newsletter

Gain Regulatory Approval in the UK in less than 14 Days!

Calling all Sponsors!

Are you concerned about Regulatory Approval timelines in the UK?

Richmond Pharmacology has recently undertaken an analysis of all studies conducted in our units over the past two years and the results speak for themselves. The average approval time for Phase I studies conducted at Richmond Pharmacology since early 2006 is 13.65 days. This is in line with the MHRA's own performance metrics published on their website. If you have any questions regarding gaining regulatory approval for your study, please contact us.

Read more…

Other archived news stories



In this section